Table 1.
Patients’ characteristics and hazard ratio for the variables in NG-tube dependence.
| Items | Values (Total n =267) |
Hazard Ratio (95% CI) | p-Value |
|---|---|---|---|
| Age | 54.55 ± 9.85 | 0.98 (0.97~1.02) | 0.94 |
| Male sex, no. (%) | 254 (95.13%) | 0.36 (0.15~0.62) | 0.01 * |
| Alcohol, no. (%) | 217 (81.27%) | 1.06 (0.64~1.74) | 0.81 |
| Betel nut, no. (%) | 205 (76.77%) | 1.08 (0.68~1.71) | 0.73 |
| Cigarette, no. (%) | 234 (87.64%) | 1.26 (0.71~2.23) | 0.42 |
| HPV-positive (%) | 81 (30.34%) | 0.54 (0.21~0.78) | 0.65 |
| IC–surgery | 171 (64.04%) | 0.23 (0.12~0.42) | 0.01 * |
| IC-CRT | 96 (35.95%) | 2.77 (1.82~4.22) | 0.01 * |
| Cancer stage | |||
| Stage 1–3 vs. 4, no. | 201/66 | 0.53 (0.27~0.96) | 0.03 * |
| TNM stage | |||
| T stage (T0–2) vs. (T3–4), no. | 186/81 | 3.04 (2.01~4.60) | 0.01 * |
| N stage (N0–1) vs. (N2–3), no. | 119/148 | 0.78 (0.51~1.18) | 0.24 |
| M stage (M0) vs. (M1), no. | 258/9 | 0.33 (0.04~2.42) | 0.28 |
* p < 0.05. HPV, human papillomaviruses; IC, induction chemotherapy; OP, operation; CRT, chemoradiotherapy; TNM, Tumor, Node, and Metastasis.